Evidence map›Paper›PMID 41883096›Full record

ArticleJournal of applied toxicology : JAT2026

Synthesis and Characterization of Juglone-Derived cu (II), Mn (II) and Zn (II) Complexes and Investigation of Their Cytotoxic Activities Against Lung and Colon Cancer Cells in Vitro and in Silico.

Mustafa Öztatlıcı, Turan Birimoğlu, Semih Güler, Rukiye Betül Çolaksel, Mehmet Tahir Husunet, Mehmet Sönmez

Abstract read
In one paragraph

Article in Journal of applied toxicology : JAT, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Mustafa ÖztatlıcıDepartment of Histology and Embryology, Gaziantep Islam Science and Technology University, Faculty of Medicine, Gaziantep, Türkiye.ORCID 0000-0001-9914-7122
Turan BirimoğluDepartment of Chemistry, Faculty of Arts and Sciences, Gaziantep University, Gaziantep, Turkey.ORCID 0000-0002-9624-3554
Semih GülerAdvanced Respiratory Biology and Respiratory Organ Cancer, Gaziantep University, Institute of Health Sciences, Gaziantep, Türkiye.ORCID 0000-0002-1821-3691
Rukiye Betül ÇolakselDepartment of Histology and Embryology, Gaziantep Islam Science and Technology University, Faculty of Medicine, Gaziantep, Türkiye.ORCID 0009-0002-5256-1259
Mehmet Tahir HusunetDepartment of Medical Genetics, Gaziantep Islam Science and Technology University, Faculty of Medicine, Gaziantep, Türkiye.ORCID 0000-0003-1424-5132
Mehmet SönmezDepartment of Chemistry, Faculty of Arts and Sciences, Gaziantep University, Gaziantep, Turkey.ORCID 0000-0003-3127-666X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Three new Zn (II), Cu (II) and Mn (II) complexes have been synthesized from 5-hydroxy-1,4-naphthoquinone (HNQ). Elemental analysis, magnetic susceptibility, UV-Vis, IR and Mass spectrometry have all been used to explore the structural characterization of these compounds. When the electronic spectra of these compounds are examined, they correspond to π → π* transitions in the 261-262 nm range, n → π* transitions in the 316-354 nm range, and charge transfer transitions in the 417-423 nm range. Also, in vitro cytotoxic activities of both juglone ligand and its metal complexes against A549 lung cancer and HT-29 colon cancer cells have been investigated. The Mn (II)-Juglone complex showed better cytotoxic activity than juglone ligand and other metal complexes in both cell lines. Moreover, molecular docking analyses demonstrated that the Mn (II)-Juglone complex exhibited stronger binding interactions with both DNA and the anti-apoptotic protein Bcl-2 compared to the free Juglone ligand. Annexin V/PI double staining results using flow cytometry showed that there were more total apoptotic cells in the Mn (II)-Juglone complex-treated groups than in the ligand-treated groups in both cell lines. In addition, it was found that Cas-3 and Bax immunoreactivity increased significantly and Bcl-2 immunoreactivity decreased significantly in Mn (II)-Juglone complex-treated groups compared to the control and ligand groups.

Indexed as

Antineoplastic AgentsColonic NeoplasmsCoordination ComplexesLung NeoplasmsManganeseNaphthoquinonesZincA549 CellsApoptosisCopperHT29 CellsHumansMolecular Docking SimulationProto-Oncogene Proteins c-bcl-2Antineoplastic AgentsCoordination ComplexesCopperjugloneManganeseNaphthoquinonesProto-Oncogene Proteins c-bcl-2Zincapoptosiscytotoxic activityJugloneJuglone metal complexes

Identifiers

PMID41883096
PMCPMC13532855

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.